Conformationally abnormal forms of tau proteins and specific antibodies thereto
CA 2437453 C · Owner: Novak, Michal · Inventors: Novak, Michal
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Invention relates to antibodies with a specificity to an abnormally truncated form of tau protein which is conformationally different from normal tau and does not bind to normal tau protein, conformationally different tau proteins ("tauons") and diagnostic and therapeutical aspects in relation to Alzheimer's disease and related tauopathies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 29, 2002 and granted June 11, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 29, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 29, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.